Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab

BMC Ophthalmology

Volumn 16, Issue 1, 2016, Pages

  Lee, Jong Wook ^a   Park, Hoon ^a   Choi, Jeong Han ^b   Lee, Hyun Joo ^a   Moon, Sang Woong ^b   Kang, Ja Heon ^b   Kim, Young Gyun ^b  

^a Eulji University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Intraocular pressure; Intravitreal injection; Mean ocular perfusion pressure

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; RANIBIZUMAB;

ADULT; ADVERSE EFFECTS; AGED; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINAL DISEASES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; RANIBIZUMAB; RETINAL DISEASES; YOUNG ADULT;

EID: 84971393008     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/s12886-016-0255-8     Document Type: Article

References (15)

1. Quigley HA, Anderson DR. Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Invest Ophthalmol Vis Sci. 1977;16:640-4.
2. Michelson G, Groh MJ, Langhans M. Perfusion of the juxtapapillary retina and optic nerve head in acute ocular hypertension. Ger J Ophthalmol. 1996;5:315-21.
3. Benz MS, Albini TA, Holz ER, Lakhanpal RR, Westfall AC, Iyer MN, Carvounis PE. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology. 2006;113:1174-8.
4. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond). 2007;23:181-5.
5. Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin). Retina. 2007;27:1044-7.
6. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42:807-11.
7. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents. Am J Ophthalmol. 2008;146:930-4.
8. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. New England J Med. 2006;355:1419-31.
9. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:623-32.
10. Pillunat LE, Anderson DR, Knighton RW, Joos KM, Feuer WJ. Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res. 1997;64:737-44.
11. Sayegh FN, Weigelin E. Functional ophthalmodynamometry. Comparison between brachial and ophthalmic blood pressure in sitting and supine position. Angiology. 1983;3:176-82.
12. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;15:85-93.
13. la Cour M, Kiilgaard JF, Eysteinsson T, Wiencke AK, Bang K, Dollerup J, Jensen PK, Stefánsson E. Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. Br J Ophthalmol. 2000;84:1045-9.
14. la Cour M, Kyhn MV, Warfvinge K, Scherfig E, Kiilgaard JF, Prause JU, Klassen H, Young M. Acute retinal ischemia caused by controlled low ocular perfusion pressure in a porcine model. Electrophysiological and histological characterisation. Exp Eye Res. 2009;88:1100-6.
15. Rasier R, Artunay O, Yuzbasioglu E, Sengul A, Bahcecioglu H. The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension. Eye (Lond). 2009;23:1714-8.